Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial

Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Haematologica (Roma) 2021-12, Vol.106 (12), p.3240-3244
Hauptverfasser: Roboz, Gail J., Doehner, Hartmut, Pocock, Christopher, Dombret, Herve, Ravandi, Farhad, Jang, Jun Ho, Selleslag, Dominik, Mayer, Ji ri, Martens, Uwe M., Liesveld, Jane, Bernal, Teresa, Wang, Ming Chung, Yu, Peiwen, Shi, Ling, Guo, Shien, La Torre, Ignazia, Skikne, Barry, Dong, Qian, Braverman, Julia, Nehme, Salem Abi, Beach, C. L., Wei, Andrew H.
Format: Artikel
Sprache:eng
Schlagworte:
Hematology
Letters to the Editor
Life Sciences & Biomedicine
Science & Technology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3244
container_issue 12
container_start_page 3240
container_title Haematologica (Roma)
container_volume 106
creator Roboz, Gail J.
Doehner, Hartmut
Pocock, Christopher
Dombret, Herve
Ravandi, Farhad
Jang, Jun Ho
Selleslag, Dominik
Mayer, Ji ri
Martens, Uwe M.
Liesveld, Jane
Bernal, Teresa
Wang, Ming Chung
Yu, Peiwen
Shi, Ling
Guo, Shien
La Torre, Ignazia
Skikne, Barry
Dong, Qian
Braverman, Julia
Nehme, Salem Abi
Beach, C. L.
Wei, Andrew H.
description
doi_str_mv 10.3324/haematol.2021.279174
format Article
fullrecord <record><control><sourceid>pubmedcentral_webof</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8634169</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>pubmedcentral_primary_oai_pubmedcentral_nih_gov_8634169</sourcerecordid><originalsourceid>FETCH-LOGICAL-p210t-11f13258eafe80ddd80ea0a50680e93ebfb6f3dd65e4fe97de6fba13aec8f66d3</originalsourceid><addsrcrecordid>eNqNUcGO1DAMrRCIHRb-gIPv0CFp2rTlgDQaLTDSoBWIvXCp3MbZBtKmJOmsht_khwhahMSNk59sv2f7Ocuec7YVoihfjUgTRme3BSv4tqhbXpcPsg2v2iJv6oI_zDZMtCyXrG4usichfGWsYG1bP84uRFlVvGJyk_289mgBf-BgolFmJlg8BfInCqDx5Dz2lsDSiSw4nVLR3K4EOCsYCW0cc08WIyn4vqI18fy7yxpNoJ2HJbXTHAPcmTgCDmskmM5knVFJc_1Gk0EwM_gEQjBufp1gWG1iaO8miGPaZ8RAcDgcXsJicaDe5YObo3fWpqkfb3Zfdp9g9-GYM8YheoP2afZIow307E-8zG7eXn3ev8-P1-8O-90xXwrOYs655qKoGkJNDVNKNYyQYbIlgVZQr3uphVKyolJTWyuSukcukIZGS6nEZfbmXndZ-4nUkC5NZnaLNxP6c-fQdP9WZjN2t-7UNVKUXLZJoLkXuEtX6TAkrwb6y2eM1enRlSwTEnxvYnLTzXu3zjFRX_w_VfwC_7eyMw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial</title><source>DOAJ Directory of Open Access Journals</source><source>Web of Science - Science Citation Index Expanded - 2021&lt;img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /&gt;</source><source>PubMed Central</source><creator>Roboz, Gail J. ; Doehner, Hartmut ; Pocock, Christopher ; Dombret, Herve ; Ravandi, Farhad ; Jang, Jun Ho ; Selleslag, Dominik ; Mayer, Ji ri ; Martens, Uwe M. ; Liesveld, Jane ; Bernal, Teresa ; Wang, Ming Chung ; Yu, Peiwen ; Shi, Ling ; Guo, Shien ; La Torre, Ignazia ; Skikne, Barry ; Dong, Qian ; Braverman, Julia ; Nehme, Salem Abi ; Beach, C. L. ; Wei, Andrew H.</creator><creatorcontrib>Roboz, Gail J. ; Doehner, Hartmut ; Pocock, Christopher ; Dombret, Herve ; Ravandi, Farhad ; Jang, Jun Ho ; Selleslag, Dominik ; Mayer, Ji ri ; Martens, Uwe M. ; Liesveld, Jane ; Bernal, Teresa ; Wang, Ming Chung ; Yu, Peiwen ; Shi, Ling ; Guo, Shien ; La Torre, Ignazia ; Skikne, Barry ; Dong, Qian ; Braverman, Julia ; Nehme, Salem Abi ; Beach, C. L. ; Wei, Andrew H.</creatorcontrib><identifier>ISSN: 0390-6078</identifier><identifier>EISSN: 1592-8721</identifier><identifier>DOI: 10.3324/haematol.2021.279174</identifier><identifier>PMID: 34551506</identifier><language>eng</language><publisher>PAVIA: Ferrata Storti Foundation</publisher><subject>Hematology ; Letters to the Editor ; Life Sciences &amp; Biomedicine ; Science &amp; Technology</subject><ispartof>Haematologica (Roma), 2021-12, Vol.106 (12), p.3240-3244</ispartof><rights>Copyright© 2021 Ferrata Storti Foundation</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>8</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000732456400031</woscitedreferencesoriginalsourcerecordid><cites>FETCH-LOGICAL-p210t-11f13258eafe80ddd80ea0a50680e93ebfb6f3dd65e4fe97de6fba13aec8f66d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634169/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8634169/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2115,27929,27930,39263,53796,53798</link.rule.ids></links><search><creatorcontrib>Roboz, Gail J.</creatorcontrib><creatorcontrib>Doehner, Hartmut</creatorcontrib><creatorcontrib>Pocock, Christopher</creatorcontrib><creatorcontrib>Dombret, Herve</creatorcontrib><creatorcontrib>Ravandi, Farhad</creatorcontrib><creatorcontrib>Jang, Jun Ho</creatorcontrib><creatorcontrib>Selleslag, Dominik</creatorcontrib><creatorcontrib>Mayer, Ji ri</creatorcontrib><creatorcontrib>Martens, Uwe M.</creatorcontrib><creatorcontrib>Liesveld, Jane</creatorcontrib><creatorcontrib>Bernal, Teresa</creatorcontrib><creatorcontrib>Wang, Ming Chung</creatorcontrib><creatorcontrib>Yu, Peiwen</creatorcontrib><creatorcontrib>Shi, Ling</creatorcontrib><creatorcontrib>Guo, Shien</creatorcontrib><creatorcontrib>La Torre, Ignazia</creatorcontrib><creatorcontrib>Skikne, Barry</creatorcontrib><creatorcontrib>Dong, Qian</creatorcontrib><creatorcontrib>Braverman, Julia</creatorcontrib><creatorcontrib>Nehme, Salem Abi</creatorcontrib><creatorcontrib>Beach, C. L.</creatorcontrib><creatorcontrib>Wei, Andrew H.</creatorcontrib><title>Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial</title><title>Haematologica (Roma)</title><addtitle>HAEMATOLOGICA</addtitle><subject>Hematology</subject><subject>Letters to the Editor</subject><subject>Life Sciences &amp; Biomedicine</subject><subject>Science &amp; Technology</subject><issn>0390-6078</issn><issn>1592-8721</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><recordid>eNqNUcGO1DAMrRCIHRb-gIPv0CFp2rTlgDQaLTDSoBWIvXCp3MbZBtKmJOmsht_khwhahMSNk59sv2f7Ocuec7YVoihfjUgTRme3BSv4tqhbXpcPsg2v2iJv6oI_zDZMtCyXrG4usichfGWsYG1bP84uRFlVvGJyk_289mgBf-BgolFmJlg8BfInCqDx5Dz2lsDSiSw4nVLR3K4EOCsYCW0cc08WIyn4vqI18fy7yxpNoJ2HJbXTHAPcmTgCDmskmM5knVFJc_1Gk0EwM_gEQjBufp1gWG1iaO8miGPaZ8RAcDgcXsJicaDe5YObo3fWpqkfb3Zfdp9g9-GYM8YheoP2afZIow307E-8zG7eXn3ev8-P1-8O-90xXwrOYs655qKoGkJNDVNKNYyQYbIlgVZQr3uphVKyolJTWyuSukcukIZGS6nEZfbmXndZ-4nUkC5NZnaLNxP6c-fQdP9WZjN2t-7UNVKUXLZJoLkXuEtX6TAkrwb6y2eM1enRlSwTEnxvYnLTzXu3zjFRX_w_VfwC_7eyMw</recordid><startdate>20211201</startdate><enddate>20211201</enddate><creator>Roboz, Gail J.</creator><creator>Doehner, Hartmut</creator><creator>Pocock, Christopher</creator><creator>Dombret, Herve</creator><creator>Ravandi, Farhad</creator><creator>Jang, Jun Ho</creator><creator>Selleslag, Dominik</creator><creator>Mayer, Ji ri</creator><creator>Martens, Uwe M.</creator><creator>Liesveld, Jane</creator><creator>Bernal, Teresa</creator><creator>Wang, Ming Chung</creator><creator>Yu, Peiwen</creator><creator>Shi, Ling</creator><creator>Guo, Shien</creator><creator>La Torre, Ignazia</creator><creator>Skikne, Barry</creator><creator>Dong, Qian</creator><creator>Braverman, Julia</creator><creator>Nehme, Salem Abi</creator><creator>Beach, C. L.</creator><creator>Wei, Andrew H.</creator><general>Ferrata Storti Foundation</general><general>Fondazione Ferrata Storti</general><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>5PM</scope></search><sort><creationdate>20211201</creationdate><title>Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial</title><author>Roboz, Gail J. ; Doehner, Hartmut ; Pocock, Christopher ; Dombret, Herve ; Ravandi, Farhad ; Jang, Jun Ho ; Selleslag, Dominik ; Mayer, Ji ri ; Martens, Uwe M. ; Liesveld, Jane ; Bernal, Teresa ; Wang, Ming Chung ; Yu, Peiwen ; Shi, Ling ; Guo, Shien ; La Torre, Ignazia ; Skikne, Barry ; Dong, Qian ; Braverman, Julia ; Nehme, Salem Abi ; Beach, C. L. ; Wei, Andrew H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p210t-11f13258eafe80ddd80ea0a50680e93ebfb6f3dd65e4fe97de6fba13aec8f66d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Hematology</topic><topic>Letters to the Editor</topic><topic>Life Sciences &amp; Biomedicine</topic><topic>Science &amp; Technology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roboz, Gail J.</creatorcontrib><creatorcontrib>Doehner, Hartmut</creatorcontrib><creatorcontrib>Pocock, Christopher</creatorcontrib><creatorcontrib>Dombret, Herve</creatorcontrib><creatorcontrib>Ravandi, Farhad</creatorcontrib><creatorcontrib>Jang, Jun Ho</creatorcontrib><creatorcontrib>Selleslag, Dominik</creatorcontrib><creatorcontrib>Mayer, Ji ri</creatorcontrib><creatorcontrib>Martens, Uwe M.</creatorcontrib><creatorcontrib>Liesveld, Jane</creatorcontrib><creatorcontrib>Bernal, Teresa</creatorcontrib><creatorcontrib>Wang, Ming Chung</creatorcontrib><creatorcontrib>Yu, Peiwen</creatorcontrib><creatorcontrib>Shi, Ling</creatorcontrib><creatorcontrib>Guo, Shien</creatorcontrib><creatorcontrib>La Torre, Ignazia</creatorcontrib><creatorcontrib>Skikne, Barry</creatorcontrib><creatorcontrib>Dong, Qian</creatorcontrib><creatorcontrib>Braverman, Julia</creatorcontrib><creatorcontrib>Nehme, Salem Abi</creatorcontrib><creatorcontrib>Beach, C. L.</creatorcontrib><creatorcontrib>Wei, Andrew H.</creatorcontrib><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Haematologica (Roma)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roboz, Gail J.</au><au>Doehner, Hartmut</au><au>Pocock, Christopher</au><au>Dombret, Herve</au><au>Ravandi, Farhad</au><au>Jang, Jun Ho</au><au>Selleslag, Dominik</au><au>Mayer, Ji ri</au><au>Martens, Uwe M.</au><au>Liesveld, Jane</au><au>Bernal, Teresa</au><au>Wang, Ming Chung</au><au>Yu, Peiwen</au><au>Shi, Ling</au><au>Guo, Shien</au><au>La Torre, Ignazia</au><au>Skikne, Barry</au><au>Dong, Qian</au><au>Braverman, Julia</au><au>Nehme, Salem Abi</au><au>Beach, C. L.</au><au>Wei, Andrew H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial</atitle><jtitle>Haematologica (Roma)</jtitle><stitle>HAEMATOLOGICA</stitle><date>2021-12-01</date><risdate>2021</risdate><volume>106</volume><issue>12</issue><spage>3240</spage><epage>3244</epage><pages>3240-3244</pages><issn>0390-6078</issn><eissn>1592-8721</eissn><cop>PAVIA</cop><pub>Ferrata Storti Foundation</pub><pmid>34551506</pmid><doi>10.3324/haematol.2021.279174</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0390-6078
ispartof Haematologica (Roma), 2021-12, Vol.106 (12), p.3240-3244
issn 0390-6078
1592-8721
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8634169
source DOAJ Directory of Open Access Journals; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; PubMed Central
subjects Hematology
Letters to the Editor
Life Sciences & Biomedicine
Science & Technology
title Oral azacitidine preserves favorable level of fatigue and health-related quality of life for patients with acute myeloid leukemia in remission: results from the phase III, placebo-controlled QUAZAR AML-001 trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T17%3A43%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmedcentral_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20azacitidine%20preserves%20favorable%20level%20of%20fatigue%20and%20health-related%20quality%20of%20life%20for%20patients%20with%20acute%20myeloid%20leukemia%20in%20remission:%20results%20from%20the%20phase%20III,%20placebo-controlled%20QUAZAR%20AML-001%20trial&rft.jtitle=Haematologica%20(Roma)&rft.au=Roboz,%20Gail%20J.&rft.date=2021-12-01&rft.volume=106&rft.issue=12&rft.spage=3240&rft.epage=3244&rft.pages=3240-3244&rft.issn=0390-6078&rft.eissn=1592-8721&rft_id=info:doi/10.3324/haematol.2021.279174&rft_dat=%3Cpubmedcentral_webof%3Epubmedcentral_primary_oai_pubmedcentral_nih_gov_8634169%3C/pubmedcentral_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34551506&rfr_iscdi=true